{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:53:18Z","timestamp":1781106798311,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-Intractable etc. (Intractable)-Designated-001"],"award-info":[{"award-number":["H29-Intractable etc. (Intractable)-Designated-001"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00204-020-02894-0","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T07:02:51Z","timestamp":1602226971000},"page":"135-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clioquinol inhibits dopamine-\u03b2-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells"],"prefix":"10.1007","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8938-1740","authenticated-orcid":false,"given":"Masato","family":"Katsuyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Ibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Yabe-Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"issue":"20","key":"2894_CR1","doi-asserted-by":"publisher","first-page":"8374","DOI":"10.1073\/pnas.0812675106","volume":"106","author":"DA Andersson","year":"2009","unstructured":"Andersson DA, Gentry C, Moss S, Bevan S (2009) Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+. Proc Natl Acad Sci USA 106(20):8374\u20138379. https:\/\/doi.org\/10.1073\/pnas.0812675106","journal-title":"Proc Natl Acad Sci USA"},{"key":"2894_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.brainres.2009.09.011","volume":"1301","author":"K Asakura","year":"2009","unstructured":"Asakura K, Ueda A, Kawamura N, Ueda M, Mihara T, Mutoh T (2009) Clioquinol inhibits NGF-induced Trk autophosphorylation and neurite outgrowth in PC12 cells. Brain Res 1301:110\u2013115. https:\/\/doi.org\/10.1016\/j.brainres.2009.09.011","journal-title":"Brain Res"},{"issue":"73","key":"2894_CR3","doi-asserted-by":"publisher","first-page":"8000","DOI":"10.1039\/c3cc42709a","volume":"49","author":"A Badarau","year":"2013","unstructured":"Badarau A, Basle A, Firbank SJ, Dennison C (2013) Crosstalk between Cu(I) and Zn(II) homeostasis via Atx1 and cognate domains. Chem Commun (Camb) 49(73):8000\u20138002. https:\/\/doi.org\/10.1039\/c3cc42709a","journal-title":"Chem Commun (Camb)"},{"issue":"1","key":"2894_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1755-5949.2010.00231.x","volume":"18","author":"SR Bareggi","year":"2012","unstructured":"Bareggi SR, Cornelli U (2012) Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther 18(1):41\u201346. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00231.x","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"2894_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.neuropharm.2005.04.023","volume":"49","author":"L Benvenisti-Zarom","year":"2005","unstructured":"Benvenisti-Zarom L, Chen J, Regan RF (2005) The oxidative neurotoxicity of clioquinol. Neuropharmacology 49(5):687\u2013694. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.04.023","journal-title":"Neuropharmacology"},{"issue":"2","key":"2894_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/BJ20110123","volume":"436","author":"MA Cater","year":"2011","unstructured":"Cater MA, Haupt Y (2011) Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. Biochem J 436(2):481\u2013491. https:\/\/doi.org\/10.1042\/BJ20110123","journal-title":"Biochem J"},{"issue":"3","key":"2894_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/s0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME et al (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron 30(3):665\u2013676. https:\/\/doi.org\/10.1016\/s0896-6273(01)00317-8","journal-title":"Neuron"},{"issue":"1","key":"2894_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuro.2008.11.001","volume":"30","author":"YT Cheung","year":"2009","unstructured":"Cheung YT, Lau WK, Yu MS et al (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30(1):127\u2013135. https:\/\/doi.org\/10.1016\/j.neuro.2008.11.001","journal-title":"Neurotoxicology"},{"issue":"45","key":"2894_CR9","doi-asserted-by":"publisher","first-page":"34056","DOI":"10.1074\/jbc.M603913200","volume":"281","author":"SM Choi","year":"2006","unstructured":"Choi SM, Choi KO, Park YK, Cho H, Yang EG, Park H (2006) Clioquinol, a Cu(II)\/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1alpha, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells. J Biol Chem 281(45):34056\u201334063. https:\/\/doi.org\/10.1074\/jbc.M603913200","journal-title":"J Biol Chem"},{"issue":"8","key":"2894_CR10","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1158\/0008-5472.CAN-04-3577","volume":"65","author":"WQ Ding","year":"2005","unstructured":"Ding WQ, Liu B, Vaught JL, Yamauchi H, Lind SE (2005) Anticancer activity of the antibiotic clioquinol. Cancer Res 65(8):3389\u20133395. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3577","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"2894_CR11","first-page":"101","volume":"32","author":"Y Egashira","year":"1982","unstructured":"Egashira Y, Matsuyama H (1982) Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases. Acta Pathologica Japonica 32(Suppl 1):101\u2013116","journal-title":"Acta Pathologica Japonica"},{"issue":"2","key":"2894_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/JAD-2010-1390","volume":"20","author":"NG Faux","year":"2010","unstructured":"Faux NG, Ritchie CW, Gunn A et al (2010) PBT2 rapidly improves cognition in Alzheimer\u2019s Disease: additional phase II analyses. J Alzheimers Dis 20(2):509\u2013516. https:\/\/doi.org\/10.3233\/JAD-2010-1390","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2894_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40478-017-0456-2","volume":"5","author":"DI Finkelstein","year":"2017","unstructured":"Finkelstein DI, Billings JL, Adlard PA et al (2017) The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. Acta Neuropathol Commun 5(1):53. https:\/\/doi.org\/10.1186\/s40478-017-0456-2","journal-title":"Acta Neuropathol Commun"},{"key":"2894_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.tox.2015.01.013","volume":"331","author":"T Fukui","year":"2015","unstructured":"Fukui T, Asakura K, Hikichi C et al (2015) Histone deacetylase inhibitor attenuates neurotoxicity of clioquinol in PC12 cells. Toxicology 331:112\u2013118. https:\/\/doi.org\/10.1016\/j.tox.2015.01.013","journal-title":"Toxicology"},{"issue":"8","key":"2894_CR15","doi-asserted-by":"publisher","first-page":"e72543","DOI":"10.1371\/journal.pone.0072543","volume":"8","author":"J Geiser","year":"2013","unstructured":"Geiser J, De Lisle RC, Finkelstein D, Adlard PA, Bush AI, Andrews GK (2013) Clioquinol synergistically augments rescue by zinc supplementation in a mouse model of acrodermatitis enteropathica. PLoS ONE 8(8):e72543. https:\/\/doi.org\/10.1371\/journal.pone.0072543","journal-title":"PLoS ONE"},{"issue":"3","key":"2894_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.18388\/abp.2015_1038","volume":"62","author":"A Grzywacz","year":"2015","unstructured":"Grzywacz A, Gdula-Argasinska J, Muszynska B, Tyszka-Czochara M, Librowski T, Opoka W (2015) Metal responsive transcription factor 1 (MTF-1) regulates zinc dependent cellular processes at the molecular level. Acta Biochim Pol 62(3):491\u2013498. https:\/\/doi.org\/10.18388\/abp.2015_1038","journal-title":"Acta Biochim Pol"},{"key":"2894_CR17","doi-asserted-by":"publisher","first-page":"10640","DOI":"10.1038\/ncomms10640","volume":"7","author":"Y Hatori","year":"2016","unstructured":"Hatori Y, Yan Y, Schmidt K et al (2016) Neuronal differentiation is associated with a redox-regulated increase of copper flow to the secretory pathway. Nat Commun 7:10640. https:\/\/doi.org\/10.1038\/ncomms10640","journal-title":"Nat Commun"},{"key":"2894_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040822","author":"KI Hayashida","year":"2019","unstructured":"Hayashida KI, Obata H (2019) Strategies to treat chronic pain and strengthen impaired descending noradrenergic inhibitory system. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20040822","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2894_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/archneur.60.9.1303","volume":"60","author":"P Hedera","year":"2003","unstructured":"Hedera P, Fink JK, Bockenstedt PL, Brewer GJ (2003) Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin: further support for existence of a new zinc overload syndrome. Arch Neurol 60(9):1303\u20131306. https:\/\/doi.org\/10.1001\/archneur.60.9.1303","journal-title":"Arch Neurol"},{"issue":"6","key":"2894_CR20","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.neuro.2009.08.008","volume":"30","author":"P Hedera","year":"2009","unstructured":"Hedera P, Peltier A, Fink JK, Wilcock S, London Z, Brewer GJ (2009) Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc. Neurotoxicology 30(6):996\u2013999. https:\/\/doi.org\/10.1016\/j.neuro.2009.08.008","journal-title":"Neurotoxicology"},{"issue":"12","key":"2894_CR21","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jps.2600621204","volume":"62","author":"DB Jack","year":"1973","unstructured":"Jack DB, Riess W (1973) Pharmacokinetics of iodochlorhydroxyquin in man. J Pharm Sci 62(12):1929\u20131932. https:\/\/doi.org\/10.1002\/jps.2600621204","journal-title":"J Pharm Sci"},{"issue":"1","key":"2894_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tox.2012.05.013","volume":"299","author":"M Katsuyama","year":"2012","unstructured":"Katsuyama M, Iwata K, Ibi M, Matsuno K, Matsumoto M, Yabe-Nishimura C (2012) Clioquinol induces DNA double-strand breaks, activation of ATM, and subsequent activation of p53 signaling. Toxicology 299(1):55\u201359. https:\/\/doi.org\/10.1016\/j.tox.2012.05.013","journal-title":"Toxicology"},{"issue":"4","key":"2894_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1254\/jphs.13271fp","volume":"124","author":"M Katsuyama","year":"2014","unstructured":"Katsuyama M, Ibi M, Matsumoto M, Iwata K, Ohshima Y, Yabe-Nishimura C (2014) Clioquinol increases the expression of VGF, a neuropeptide precursor, through induction of c-Fos expression. J Pharmacol Sci 124(4):427\u2013432. https:\/\/doi.org\/10.1254\/jphs.13271fp","journal-title":"J Pharmacol Sci"},{"key":"2894_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuro.2018.06.014","volume":"67","author":"M Katsuyama","year":"2018","unstructured":"Katsuyama M, Ibi M, Iwata K, Matsumoto M, Yabe-Nishimura C (2018) Clioquinol increases the expression of interleukin-8 by down-regulating GATA-2 and GATA-3. Neurotoxicology 67:296\u2013304. https:\/\/doi.org\/10.1016\/j.neuro.2018.06.014","journal-title":"Neurotoxicology"},{"issue":"1","key":"2894_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbrc.2014.04.067","volume":"452","author":"K Kawamura","year":"2014","unstructured":"Kawamura K, Kuroda Y, Sogo M, Fujimoto M, Inui T, Mitsui T (2014) Superoxide dismutase as a target of clioquinol-induced neurotoxicity. Biochem Biophys Res Commun 452(1):181\u2013185. https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.067","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2894_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1074\/jbc.275.1.580","volume":"275","author":"GS Kelner","year":"2000","unstructured":"Kelner GS, Lee M, Clark ME et al (2000) The copper transport protein Atox1 promotes neuronal survival. J Biol Chem 275(1):580\u2013584. https:\/\/doi.org\/10.1074\/jbc.275.1.580","journal-title":"J Biol Chem"},{"issue":"2","key":"2894_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sc.2010.68","volume":"49","author":"E Kimura","year":"2011","unstructured":"Kimura E, Hirano T, Yamashita S et al (2011) Cervical MRI of subacute myelo-optico-neuropathy. Spinal Cord 49(2):182\u2013185. https:\/\/doi.org\/10.1038\/sc.2010.68","journal-title":"Spinal Cord"},{"issue":"3","key":"2894_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neulet.2008.07.079","volume":"443","author":"T Kume","year":"2008","unstructured":"Kume T, Kawato Y, Osakada F et al (2008) Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. Neurosci Lett 443(3):199\u2013203. https:\/\/doi.org\/10.1016\/j.neulet.2008.07.079","journal-title":"Neurosci Lett"},{"issue":"3","key":"2894_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ng913","volume":"31","author":"S Kury","year":"2002","unstructured":"Kury S, Dreno B, Bezieau S et al (2002) Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 31(3):239\u2013240. https:\/\/doi.org\/10.1038\/ng913","journal-title":"Nat Genet"},{"issue":"44","key":"2894_CR30","doi-asserted-by":"publisher","first-page":"34803","DOI":"10.1074\/jbc.M007339200","volume":"275","author":"SJ Langmade","year":"2000","unstructured":"Langmade SJ, Ravindra R, Daniels PJ, Andrews GK (2000) The transcription factor MTF-1 mediates metal regulation of the mouse ZnT1 gene. J Biol Chem 275(44):34803\u201334809. https:\/\/doi.org\/10.1074\/jbc.M007339200","journal-title":"J Biol Chem"},{"issue":"9","key":"2894_CR31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","volume":"7","author":"L Lannfelt","year":"2008","unstructured":"Lannfelt L, Blennow K, Zetterberg H et al (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer\u2019s disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7(9):779\u2013786. https:\/\/doi.org\/10.1016\/S1474-4422(08)70167-4","journal-title":"Lancet Neurol"},{"issue":"2","key":"2894_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molbrainres.2003.10.013","volume":"120","author":"PA Li","year":"2004","unstructured":"Li PA, He Q, Cao T et al (2004) Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res Mol Brain Res 120(2):115\u2013122. https:\/\/doi.org\/10.1016\/j.molbrainres.2003.10.013","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"2894_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neuron.2010.08.013","volume":"68","author":"J Li","year":"2010","unstructured":"Li J, Gu X, Ma Y et al (2010) Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-kappaB signaling. Neuron 68(1):45\u201360. https:\/\/doi.org\/10.1016\/j.neuron.2010.08.013","journal-title":"Neuron"},{"issue":"9","key":"2894_CR34","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1073\/pnas.92.9.3784","volume":"92","author":"SJ Lin","year":"1995","unstructured":"Lin SJ, Culotta VC (1995) The ATX1 gene of Saccharomyces cerevisiae encodes a small metal homeostasis factor that protects cells against reactive oxygen toxicity. Proc Natl Acad Sci USA 92(9):3784\u20133788. https:\/\/doi.org\/10.1073\/pnas.92.9.3784","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2894_CR35","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1038\/s41598-020-60953-z","volume":"10","author":"S Maghool","year":"2020","unstructured":"Maghool S, Fontaine S, Roberts BR, Kwan AH, Maher MJ (2020) Human glutaredoxin-1 can transfer copper to isolated metal binding domains of the P1B-type ATPase, ATP7B. Sci Rep 10(1):4157. https:\/\/doi.org\/10.1038\/s41598-020-60953-z","journal-title":"Sci Rep"},{"issue":"1","key":"2894_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1046\/j.1471-4159.2001.t01-1-00231.x","volume":"77","author":"A Malaspina","year":"2001","unstructured":"Malaspina A, Kaushik N, de Belleroche J (2001) Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 77(1):132\u2013145. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.t01-1-00231.x","journal-title":"J Neurochem"},{"issue":"3","key":"2894_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/leu.2008.232","volume":"23","author":"X Mao","year":"2009","unstructured":"Mao X, Li X, Sprangers R et al (2009) Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma. Leukemia 23(3):585\u2013590. https:\/\/doi.org\/10.1038\/leu.2008.232","journal-title":"Leukemia"},{"issue":"5","key":"2894_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/bf00295093","volume":"59","author":"Y Matsuki","year":"1987","unstructured":"Matsuki Y, Ito T, Fukuhara K, Abe M, Othaki T, Nambara T (1987) Determination of chinoform in biological fluids and nervous tissues of the dog by gas chromatography-mass spectrometry. Arch Toxicol 59(5):374\u2013378. https:\/\/doi.org\/10.1007\/bf00295093","journal-title":"Arch Toxicol"},{"issue":"3","key":"2894_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jech.29.3.157","volume":"29","author":"TW Meade","year":"1975","unstructured":"Meade TW (1975) Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis. Br J Prev Soc Med 29(3):157\u2013169. https:\/\/doi.org\/10.1136\/jech.29.3.157","journal-title":"Br J Prev Soc Med"},{"issue":"7796","key":"2894_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0140-6736(73)90004-4","volume":"1","author":"K Nakae","year":"1973","unstructured":"Nakae K, Yamamoto S, Shigematsu I, Kono R (1973) Relation between subacute myelo-optic neuropathy (S.M.O.N.) and clioquinol: nationwide survey. Lancet 1(7796):171\u2013173. https:\/\/doi.org\/10.1016\/s0140-6736(73)90004-4","journal-title":"Lancet"},{"issue":"9","key":"2894_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1212\/01.wnl.0000312375.79881.94","volume":"71","author":"SP Nations","year":"2008","unstructured":"Nations SP, Boyer PJ, Love LA et al (2008) Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 71(9):639\u2013643. https:\/\/doi.org\/10.1212\/01.wnl.0000312375.79881.94","journal-title":"Neurology"},{"issue":"5","key":"2894_CR42","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1158\/0008-5472.CAN-10-1516","volume":"71","author":"F Pez","year":"2011","unstructured":"Pez F, Dayan F, Durivault J et al (2011) The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res 71(5):1647\u20131657. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1516","journal-title":"Cancer Res"},{"issue":"12","key":"2894_CR43","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A et al (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60(12):1685\u20131691. https:\/\/doi.org\/10.1001\/archneur.60.12.1685","journal-title":"Arch Neurol"},{"issue":"52","key":"2894_CR44","doi-asserted-by":"publisher","first-page":"20085","DOI":"10.1074\/jbc.RA118.004889","volume":"293","author":"K Schmidt","year":"2018","unstructured":"Schmidt K, Ralle M, Schaffer T et al (2018) ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine-beta-hydroxylase. J Biol Chem 293(52):20085\u201320098. https:\/\/doi.org\/10.1074\/jbc.RA118.004889","journal-title":"J Biol Chem"},{"issue":"8","key":"2894_CR45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00415-006-0479-2","volume":"254","author":"M Spinazzi","year":"2007","unstructured":"Spinazzi M, De Lazzari F, Tavolato B, Angelini C, Manara R, Armani M (2007) Myelo-optico-neuropathy in copper deficiency occurring after partial gastrectomy. Do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance? J Neurol 254(8):1012\u20131017. https:\/\/doi.org\/10.1007\/s00415-006-0479-2","journal-title":"J Neurol"},{"issue":"3","key":"2894_CR46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1542\/peds.65.3.610","volume":"65","author":"FM Sturtevant","year":"1980","unstructured":"Sturtevant FM (1980) Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols. Pediatrics 65(3):610\u2013613","journal-title":"Pediatrics"},{"issue":"1","key":"2894_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/toxsci\/kfz043","volume":"169","author":"KI Tanaka","year":"2019","unstructured":"Tanaka KI, Shimoda M, Kasai M, Ikeda M, Ishima Y, Kawahara M (2019) Involvement of SAPK\/JNK signaling pathway in copper enhanced zinc-induced neuronal cell death. Toxicol Sci 169(1):293\u2013302. https:\/\/doi.org\/10.1093\/toxsci\/kfz043","journal-title":"Toxicol Sci"},{"issue":"Suppl","key":"2894_CR48","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1046\/j.1440-1789.2000.00296.x","volume":"20","author":"J Tateishi","year":"2000","unstructured":"Tateishi J (2000) Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals. Neuropathology 20(Suppl):S20\u2013S24. https:\/\/doi.org\/10.1046\/j.1440-1789.2000.00296.x","journal-title":"Neuropathology"},{"issue":"12","key":"2894_CR49","doi-asserted-by":"publisher","first-page":"8666","DOI":"10.1016\/S0021-9258(18)42494-5","volume":"267","author":"PC Trackman","year":"1992","unstructured":"Trackman PC, Bedell-Hogan D, Tang J, Kagan HM (1992) Post-translational glycosylation and proteolytic processing of a lysyl oxidase precursor. J Biol Chem 267(12):8666\u20138671","journal-title":"J Biol Chem"},{"issue":"7701","key":"2894_CR50","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/s0140-6736(71)92699-7","volume":"1","author":"T Tsubaki","year":"1971","unstructured":"Tsubaki T, Honma Y, Hoshi M (1971) Neurological syndrome associated with clioquinol. Lancet 1(7701):696\u2013697. https:\/\/doi.org\/10.1016\/s0140-6736(71)92699-7","journal-title":"Lancet"},{"issue":"33","key":"2894_CR51","doi-asserted-by":"publisher","first-page":"10754","DOI":"10.1021\/ja0610030","volume":"128","author":"EM van Dongen","year":"2006","unstructured":"van Dongen EM, Dekkers LM, Spijker K, Meijer EW, Klomp LW, Merkx M (2006) Ratiometric fluorescent sensor proteins with subnanomolar affinity for Zn(II) based on copper chaperone domains. J Am Chem Soc 128(33):10754\u201310762. https:\/\/doi.org\/10.1021\/ja0610030","journal-title":"J Am Chem Soc"},{"issue":"8","key":"2894_CR52","first-page":"1086","volume":"123","author":"HR Xie","year":"2010","unstructured":"Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin Med J 123(8):1086\u20131092","journal-title":"Chin Med J"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02894-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-020-02894-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02894-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T19:07:09Z","timestamp":1669144029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-020-02894-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2894"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02894-0","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose with respect to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript does not involve clinical studies or contain patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}